We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MDBIF market cap is 3.63M. The company's latest EPS is AUD -0.0148 and P/E is 0.00.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 4.1M | 926k | 1.27M | 1.01M | 960k |
| Operating Income | -6.06M | -3.64M | -1.47M | -12.71M | -3.06M |
| Net Income | -6.59M | -3.87M | -1.49M | -12.72M | -3.07M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 13.3M | 14.01M | 17.38M | 8.49M | 8.03M |
| Total Liabilities | 4.7M | 1.41M | 964k | 1.38M | 1.69M |
| Total Equity | 8.6M | 12.61M | 16.42M | 7.11M | 6.34M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -6.86M | -3.59M | -1.7M | -1.66M | -932k |
| Investing | -1.06M | -1.5M | -1.83M | -2.97M | -2.26M |
| Financing | 3.13M | 4.55M | 4.92M | 3.29M | 2.47M |
| Market Cap | 3.63M |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 207.53M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -4.89% |
| 52 Week High | 0.028 |
| 52 Week Low | 0.01 |
| Spread (Intraday) | 80.07 (100%) |
| Company Name | TrivarX Ltd (PK) |
| Address |
level 4 melbourne, victoria 3205 |
| Website | https://www.medibio.com.au |
| Industry | pharmaceutical biolog/vaccines (H23) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
